Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
36.12 USD | -2.36% |
|
-2.43% | -21.43% |
Kurzporträt
Mitarbeiterzahl: 255
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Ian Mortimer
CEO | Chief Executive Officer | 48 | 21.10.13 |
Sherry Aulin
DFI | Director of Finance/CFO | 41 | 01.01.11 |
Chief Tech/Sci/R&D Officer | 53 | 23.08.21 | |
Sheila M. Grant
CTO | Chief Tech/Sci/R&D Officer | - | 01.08.20 |
Jodi Regts
IRO | Public Communications Contact | - | 01.12.15 |
Corporate Officer/Principal | 45 | 17.08.20 | |
Andrea DiFabio
LAW | General Counsel | 55 | 07.11.22 |
James Empfield
PRN | Corporate Officer/Principal | - | 01.02.16 |
Corporate Officer/Principal | 63 | 01.03.01 | |
Human Resources Officer | 64 | 17.09.19 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Clarence Machado
BRD | Director/Board Member | 60 | 05.11.20 |
Justin Gover
BRD | Director/Board Member | 53 | 08.08.23 |
Gary Patou
BRD | Director/Board Member | 65 | 01.01.04 |
Steven Gannon
BRD | Director/Board Member | 62 | 21.05.15 |
Ian Mortimer
CEO | Chief Executive Officer | 48 | 21.10.13 |
Dawn Svoronos
BRD | Director/Board Member | 70 | 27.09.16 |
Director/Board Member | 66 | 03.06.21 | |
Gillian Cannon
BRD | Director/Board Member | 60 | 08.08.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 75 468 883 | 74 291 475 ( 98,44 %) | 0 | 98,44 % |
Unternehmenskontakt
Xenon Pharmaceuticals, Inc.
3650 Gilmore Way Suite 200
V5G 4W8, Burnaby
+604 484 3300
http://www.xenon-pharma.com![Straße Xenon Pharmaceuticals Inc.(XENE)](https://cdn.zonebourse.com/static/address/18411162.png)
Sektor
![Analystenschätzungen](/images/consensus_flch.gif)
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-21.43% | 2.79 Mrd. | |
+17.04% | 122 Mrd. | |
+21.83% | 116 Mrd. | |
+22.18% | 27.03 Mrd. | |
-21.45% | 20.36 Mrd. | |
-16.89% | 16.43 Mrd. | |
-18.35% | 15.91 Mrd. | |
-44.74% | 15.6 Mrd. | |
+62.96% | 14.94 Mrd. | |
+2.97% | 13.59 Mrd. |
- Börse
- Aktien
- A12ETN Aktie
- Unternehmen Xenon Pharmaceuticals Inc.